312
Views
0
CrossRef citations to date
0
Altmetric
Original Research

A retrospective study comparing the results of continuous glucose monitoring to self-blood glucose monitoring for pregnant women with type 1 diabetes mellitus

ORCID Icon, ORCID Icon, , , , , , , , & show all
Received 01 Oct 2023, Accepted 25 Mar 2024, Published online: 13 May 2024

References

  • Maresh MJ, Holmes VA, Patterson CC, et al. Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes. Diabetes Care. 2015 Jan;38(1):34–42. doi: 10.2337/dc14-1755
  • McGrath RT, Glastras SJ, Hocking SL, et al. Large-for-gestational-age neonates in type 1 diabetes and pregnancy: contribution of factors beyond hyperglycemia. Diabetes Care. 2018;41(8):1821. doi: 10.2337/dc18-0551
  • Clausen TD, Mathiesen ER, Hansen T, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care. 2008 Feb;31(2):340–346. doi: 10.2337/dc07-1596
  • Holmes VA, Young IS, Patterson CC, et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care. 2011 Aug;34(8):1683–1688. doi: 10.2337/dc11-0244
  • American Diabetes A. 14. management of diabetes in pregnancy: standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Supplement 1):S200. doi: 10.2337/dc21-S014
  • Excellence NIfHa C. Diabetes in pregnancy: management from preconception to the postnatal period 2020. [cited 2020 Dec 16]. Available from: https://www.nice.org.uk/guidance/ng3/resources
  • Goudie RJB, Lunn D, Hovorka R, et al. Pharmacokinetics of insulin aspart in pregnant women with type 1 diabetes: every day is different. Diabetes Care. 2014;37(6):e121. doi: 10.2337/dc13-2535
  • Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, et al. Hypoglycaemia during pregnancy in women with type 1 diabetes. Diabet Med. 2012 May;29(5):558–566. doi: 10.1111/j.1464-5491.2012.03604.x
  • Bumbu A, Moutairou A, Matar O, et al. Non-severe hypoglycaemia is associated with weight gain in patients with type 1 diabetes: results from the diabetes control and complication trial. Diabetes Obesity Metab. 2018;20(5):1289–1292. doi: 10.1111/dom.13197
  • Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study G, Tamborlane WV, Beck RW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008 Oct 2;359(14):1464–1476.
  • Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. [2011 Jul 7];343(jul07 1):d3805. doi: 10.1136/bmj.d3805
  • Yu F, Lv L, Liang Z, et al. Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study. J Clin Endocrinol Metab. 2014 Dec;99(12):4674–4682. doi: 10.1210/jc.2013-4332
  • Paramasivam SS, Chinna K, Singh AKK, et al. Continuous glucose monitoring results in lower HbA1c in Malaysian women with insulin-treated gestational diabetes: a randomized controlled trial. Diabet Med. 2018 Aug;35(8):1118–1129. doi: 10.1111/dme.13649
  • Feig DS, Donovan LE, Corcoy R, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017 Nov 25;390(10110):2347–2359. doi: 10.1016/S0140-6736(17)32400-5
  • Murphy HR, Rayman G, Lewis K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ. 2008;337(sep25 2):a1680. doi: 10.1136/bmj.a1680
  • Voormolen DN, DeVries JH, Sanson RME, et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes Obesity Metab. 2018;20(8):1894–1902. doi: 10.1111/dom.13310
  • Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in range. Diabetes Care. 2019 Aug;42(8):1593–1603. doi: 10.2337/dci19-0028
  • Allen K, Wallace SVF. Fetal macrosomia. Obstet Gynaecol Reprod Med. 2013 Jun 01;23(6):185–188. doi: 10.1016/j.ogrm.2013.03.012
  • Schlaudecker EP, Munoz FM, Bardají A, et al. Small for gestational age: case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. Vaccine. 2017 Dec 4;35(48):6518–6528. doi: 10.1016/j.vaccine.2017.01.040
  • Weight gain during pregnancy. Washington DCNAP. doi: 10.17226/12584
  • ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019 Jan;133(1):1.
  • American Diabetes A. 8. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes—2020. Diabetes Care. 2019;43(Supplement_1):S89–S97.
  • Lemaitre M, Ternynck C, Bourry J, et al. Association between HbA1c levels on adverse pregnancy outcomes during pregnancy in patients with type 1 diabetes. J Clin Endocrinol Metab. 1125 2022 Feb 17;107(3):e1117–e. doi: 10.1210/clinem/dgab769
  • Bashir M, Naem E, Taha F, et al. Outcomes of type 1 diabetes mellitus in pregnancy; effect of excessive gestational weight gain and hyperglycaemia on fetal growth. Diabetes Metab Syndr. 2019 Jan;13(1):84–88. doi: 10.1016/j.dsx.2018.08.030
  • Secher AL, Ringholm L, Andersen HU, et al. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care. 2013 Jul;36(7):1877–1883. doi: 10.2337/dc12-2360
  • Murphy HR, Howgate C, O’Keefe J, et al. Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study. Lancet Diabetes Endocrinol. 2021 Mar;9(3):153–164. doi: 10.1016/S2213-8587(20)30406-X
  • Evers IM, de Valk HW, Mol BW, et al. Macrosomia despite good glycaemic control in type I diabetic pregnancy; results of a nationwide study in the Netherlands. Diabetologia. 2002 Nov;45(11):1484–1489. doi: 10.1007/s00125-002-0958-7
  • Ladfors L, Shaat N, Wiberg N, et al. Fetal overgrowth in women with type 1 and type 2 diabetes mellitus. PLOS ONE. 2017;12(11):e0187917. doi: 10.1371/journal.pone.0187917
  • Perea V, Picón MJ, Megia A, et al. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes. Diabetologia. 2022 Aug;65(8):1302–1314. doi: 10.1007/s00125-022-05717-2
  • Bashir M, Navti OB, Ahmed B, et al. Hyperlipidaemia and severe hypertriglyceridaemia in pregnancy. Obstet Gynaecol. 2023 Sep 01;25(3):196–209. doi: 10.1111/tog.12887
  • McGrath RT, Glastras SJ, Hocking SL, et al. Large-for-gestational-age neonates in type 1 diabetes and pregnancy: contribution of factors beyond hyperglycemia. Diabetes Care. 2018;41(8):1821–1828. doi: 10.2337/dc18-0551